Our HIV business is managed thru ViiV Healthcare, an international expert HIV agency established in 2009, that we majority own, with Pfizer and Shionogi as shareholders. A optimal global company concentrated on advancing technological know-how into HIV treatment, prevention and care, ViiV Healthcare has had big recent successes with regulatory approvals and industry most desirable launches of new antiretrovirals. ViiV Healthcare’s present portfolio of 13 HIV treatments generated annual sales of £4. 854 billion in 2019.
A pipeline of capacity future antiretroviral drugs is also in medical development.